Through our recent efforts in conducting in silico screening and cellular-based assays [10], we discovered Inauhzin (INZ) and its analogs (Figure 1) as a novel class of small molecules that effectively activate p53 and promote p53-dependent apoptosis of human cancer cells without causing apparently genotoxic stress. This evidence concerns the gene TP53 and cancer.